Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ohno

Showing results (331-340 of 400) with videos related to

Pageof 40
Sort By:
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
Phase I clinical and pharmacokinetic study of N4-behenoyl-1-beta-D-arabinofuranosylcytosineK Kimura, R Ohno, I Amaki, et al.
Bone Marrow Transplantation|April 1, 1993
Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complementY Morishima, K Miyamura, S Kojima, et al.
Leukemia|August 1, 1993
Unexpected heterogeneity of PML/RAR alpha fused mRNA detected by nested polymerase chain reaction in acute promyelocytic leukemiaA Matsuoka, K Miyamura, N Emi, et al.
Leukemia|March 1, 1997
Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocationsK Tanaka, M Arif, M Eguchi, et al.
Endocrine Journal|December 2, 1999
Growth hormone advances spermatogenesis in premature rats treated with gonadotropin-releasing hormone agonistK Ohyama, N Iwatani, Y Nakagomi, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2006
Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trialH Saito, I Maruyama, S Shimazaki, et al.
European Journal of Endocrinology|August 7, 2004
Nicorandil improves diabetes and rat islet beta-cell damage induced by streptozotocin in vivo and in vitroK Kasono, T Yasu, A Kakehashi, et al.
Japanese Journal of Clinical Oncology|December 1, 1996
Combination phase I/II study of irinotecan hydrochloride (CPT-11) and carboplatin in relapsed or refractory non-Hodgkin's lymphoma. CPT-11/Lymphoma Study GroupK Tobinai, T Hotta, H Saito, et al.
Leukemia|August 15, 2000
Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublinesK Naito, A Takeshita, K Shigeno, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysisK Ohnishi, T Ino, Y Kishimoto, et al.
Pageof 40

Showing results (331-340 of 400) with videos related to

Sort By:
Pageof 40
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
Phase I clinical and pharmacokinetic study of N4-behenoyl-1-beta-D-arabinofuranosylcytosineK Kimura, R Ohno, I Amaki, et al.
Bone Marrow Transplantation|April 1, 1993
Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complementY Morishima, K Miyamura, S Kojima, et al.
Leukemia|August 1, 1993
Unexpected heterogeneity of PML/RAR alpha fused mRNA detected by nested polymerase chain reaction in acute promyelocytic leukemiaA Matsuoka, K Miyamura, N Emi, et al.
Leukemia|March 1, 1997
Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocationsK Tanaka, M Arif, M Eguchi, et al.
Endocrine Journal|December 2, 1999
Growth hormone advances spermatogenesis in premature rats treated with gonadotropin-releasing hormone agonistK Ohyama, N Iwatani, Y Nakagomi, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2006
Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trialH Saito, I Maruyama, S Shimazaki, et al.
European Journal of Endocrinology|August 7, 2004
Nicorandil improves diabetes and rat islet beta-cell damage induced by streptozotocin in vivo and in vitroK Kasono, T Yasu, A Kakehashi, et al.
Japanese Journal of Clinical Oncology|December 1, 1996
Combination phase I/II study of irinotecan hydrochloride (CPT-11) and carboplatin in relapsed or refractory non-Hodgkin's lymphoma. CPT-11/Lymphoma Study GroupK Tobinai, T Hotta, H Saito, et al.
Leukemia|August 15, 2000
Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublinesK Naito, A Takeshita, K Shigeno, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysisK Ohnishi, T Ino, Y Kishimoto, et al.
Pageof 40